Member access

4-Traders Homepage  >  News


Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

MARKET COMMENT : Sensex Likely Down, 19,200 Support - Dealer

02/21/2013 | 10:46pm US/Eastern

0330 GMT [Dow Jones] The Sensex is likely to open lower on negative cues from most regional markets following weak economic data from Europe and as investor mood remains cautious ahead of the crucial annual budget announcement at the month-end, say dealers. "The benchmark is called to start 35-50 points lower, led by selling by domestic institutions in banks and select consumer names," says a dealer. He adds, the index closed near its intraday low last session and a falling local currency against the U.S. dollar will further weigh on trade. He tips the Sensex to find immediate support at 19,200. Another market dealer says short-covering after a sharp sell-off Thursday and foreign fund inflows--they purchased stocks worth a provisional INR12.14 billion--will support and limit a sharp fall. The Sensex ended down 1.6% at 19,325.36 Thursday--its biggest single-day loss in about seven months. (

Contact us in Singapore. 65 64154 140; 

Subscribe to WSJ:

Latest news
Date Title
<1m agoDJGFI Group Board Committee to Review Unsolicited Bid From BGC Partners
1m ago New Findings on Addiction Research Discussed by Researchers at National Institute on Drug Abuse (Crosswalk between DSM-IV dependence and DSM-5...
1m ago Takata shares fall sharply, hit 1 1/2-year low
1m ago JOHNSON & JOHNSON : Family of Consumer Companies Turns Brands Purple in Support of Spirit Day
3m ago STAPLES : Postal workers appeal to Harvard president
4m ago WOLTERS KLUWER : Parents' perception of teens' experiences are related to mental health
4m ago WORLD WRESTLING ENTERTAINMENT : Trademark Application for "WWE SLAM CITY" Filed
4m ago Trademark Application for "SNOW RIPPER" Filed by Mattel
4m ago ARCHER DANIELS MIDLAND : ADM to Release Third Quarter Financial Results on Nov. 4, 2014
4m ago ARENA PHARMACEUTICALS : Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® lorcaserin HCl CIV in Postgraduate Medicine
Latest news
Hot News 
BOULDER BRANDS : Announces Preliminary Third Quarter 2014 Results
TUPPERWARE BRANDS : Reports Third Quarter Results
WILLBROS : Elects John T. McNabb, II Chief Executive Officer
ALTISOURCE PORTFOLIO SOLUTIONS : INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Altisource Portfolio Solutions S.A.
Most Read News
1h ago AT&T revenue misses forecasts as more customers bring own phones
2h ago TERADYNE : beats Street 3Q forecasts
2h ago EXELON : ICC Approves ComEd’s Grand Prairie Gateway Project
2h ago ATMEL : Patent Issued for Apparatus and Method for Increasing the Quantity of Discrete Electronic Components in an Integrated Circuit Package
2h ago TESORO LOGISTICS : Announces Pricing of $1.3 Billion of Senior Notes
Most recommended articles
<1m ago Takata shares fall sharply, hit 1 1/2-year low
26m ago Crude Plummets To Critical Barrier, Gold Slumps On US CPI Surprise
27m ago GBP/USD TECHNICAL ANALYSIS : Eyeing Support Below 1.60
27m ago USD/CHF TECHNICAL ANALYSIS : Aiming to Get Long Below 0.95
32m ago Private capital gets more bang in China as economic reforms step up
Dynamic quotes